Cases | Total cohort1 | |||||
---|---|---|---|---|---|---|
Adenocarcinoma | Squamous cell carcinoma | Other or undifferentiated morphology | All cases | |||
Subjects, n | 114 | 184 | 26 | 324 | 577259 | |
Sex | Male | 102 (89.5) | 144 (78.3) | 22 (84.6) | 268 (82.7) | 288930 (50.1) |
Female | 12 (10.5) | 40 (21.7) | 4 (15.4) | 56 (17.3) | 288329 (49.9) | |
Age at baseline, mean (SD) | 49.6 (10.1) | 51.0 (10.9) | 51.2 (10.1) | 50.5 (10.5) | 44.0 (11.7) | |
Cohort, n (%) | Oslo | 13 (11.4) | 37 ((20.1) | 5 (19.2) | 55 (17.0) | 16714 (2.9) |
NCS | 31 (27.2) | 29 (15.8) | 4 (15.4) | 64 (19.8) | 50922 (8.8) | |
CONOR | 10 (8.8) | 14 (7.6) | 3 (11.5) | 27 (8.3) | 109403 (19.0) | |
40-y | 5 (4.4) | 6 (3.3) | 1 (3.8) | 12 (3.7) | 128742 (22.3) | |
VHM&PP | 16 (14.0) | 40 (21.7) | 5 (19.2) | 61 (18.8) | 159444 (27.6) | |
VIP | 16 (14.0) | 8 (4.3) | 1 (3.8) | 25 (7.7) | 79360 (13.7) | |
MPP | 23 (20.2) | 50 (27.2) | 7 (26.9) | 80 (24.7) | 32674 (5.7) | |
Fasting time, n (%) | < 4 hrs | 43 (37.7) | 64 (34.8) | 8 (30.8) | 115 (35.5) | 242246 (42.0) |
4-8 hrs | 14 (12.3) | 14 (7.6) | 5 (19.2) | 33 (10.2) | 57409 (9.9) | |
> 8 hrs | 57 (50.0) | 106 (57.6) | 13 (50.0) | 176 (54.3) | 277604 (48.1) | |
BMI, mean (SD) | 27.1 (3.8) | 24.0 (3.3) | 26.0 (4.2) | 25.3 (3.8) | 25.3 (4.0) | |
Mid BP2 mmHg, mean (SD) | 110.6 (12.9) | 112.4 (15.3) | 111.9 (12.7) | 111.7 (14.3) | 104.4 (13.7) | |
Glucose mmol/l, median (IQR) | 5.4 (4.8-5.4) | 5.3 (4.7-5.3) | 5.1 (4.6-5.6) | 5.3 (4.7-5.9) | 5.1 (4.6-5.6) | |
Cholesterol mmol/l, mean (SD) | 6.1 (1.1) | 6.2 (1.1) | 6.4 (1.3) | 6.2 (1.1) | 5.7 (1.2) | |
Triglycerides mmol/l, median (IQR) | 1.63 (1.11-2.43) | 1.44 (1.02-2.11) | 1.82 (1.12-2.80) | 1.57 (1.05-2.33) | 1.29 (0.91-1.91) | |
Smoking status, n (%) | Never | 25 (21.9) | 29 (15.8) | 4 (15.4) | 58 (17.9) | 257721 (44.6) |
Former | 36 (31.6) | 25 (13.6) | 5 (19.2) | 66 (20.4) | 158358 (27.4) | |
Current | 52 (45.6) | 129 (70.1) | 17 (65.4) | 198 (61.1) | 159624 (27.7) | |
Missing | 1 (0.9) | 1 (0.5) | 0 | 2 (0.6) | 1556 (0.3) |